Delving into the Latest Updates on RSV mRNA vaccine(Namicin) with Synapse

Overview

Basic Info

Drug Type

Prophylactic vaccine, mRNA vaccine

Synonyms

冻干mRNA呼吸道合胞病毒（RSV）疫苗(纳美信), NR222

Target-

Action

stimulants

Mechanism

Immunostimulants

Therapeutic Areas

Infectious Diseases

Active Indication

Respiratory Syncytial Virus Infections

Inactive Indication-

Originator Organization

Namicin (Shanghai) Biotechnology Co., Ltd.

Active Organization

Namicin (Shanghai) Biotechnology Co., Ltd.

Inactive Organization-

License Organization

Namicin (Shanghai) Biotechnology Co., Ltd.

Chengdu Kanghua Biological Products Co., Ltd.

Drug Highest PhasePhase 1

First Approval Date-

Regulation-

Login to view timeline

主要目的：评价冻干呼吸道合胞病毒mRNA疫苗在18周岁及以上受试者中接种的安全性和耐受性。次要目的：评价冻干呼吸道合胞病毒mRNA疫苗在18周岁及以上受试者中接种的免疫原性。探索性目的： (1) 评价冻干呼吸道合胞病毒mRNA疫苗在18周岁及以上受试者中接种的免疫持久性； (2) 评价冻干呼吸道合胞病毒mRNA疫苗在18周岁及以上受试者中接种的细胞免疫情况。

[Translation]

Primary objective: To evaluate the safety and tolerability of freeze-dried respiratory syncytial virus mRNA vaccine in subjects aged 18 years and above. Secondary objective: To evaluate the immunogenicity of freeze-dried respiratory syncytial virus mRNA vaccine in subjects aged 18 years and above. Exploratory objectives: (1) To evaluate the immune persistence of freeze-dried respiratory syncytial virus mRNA vaccine in subjects aged 18 years and above; (2) To evaluate the cellular immunity of freeze-dried respiratory syncytial virus mRNA vaccine in subjects aged 18 years and above.

Start Date10 Sep 2025

Sponsor / Collaborator

Namicin (Shanghai) Biotechnology Co., Ltd.

100 Clinical Results associated with RSV mRNA vaccine(Namicin)

Login to view more data

100 Translational Medicine associated with RSV mRNA vaccine(Namicin)

Login to view more data

100 Patents (Medical) associated with RSV mRNA vaccine(Namicin)

Login to view more data

100 Deals associated with RSV mRNA vaccine(Namicin)

Login to view more data